Paul W Wong - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Molecular Vision|July 4, 2014

Generation of a foveomacular transcriptomeAlison Ziesel, Steven Bernstein, Paul W Wong

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002

Infantile cystinosis presenting as chronic constipationFarahnak K Assadi, Richard H Sandler, Paul W Wong, et al.

Genomics|March 19, 2004

Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expressionMd Nawajes A Mandal, Rajesh Ambasudhan, Paul W Wong, et al.

Investigative Ophthalmology & Visual Science|June 26, 2003

Evolutionarily conserved ELOVL4 gene expression in the vertebrate retinaPamela S Lagali, Jiafan Liu, Rajesh Ambasudhan, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 18, 2005

Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascadesAyala Hezi-Yamit, Paul W Wong, Nga Bien-Ly, et al.

Genomics|March 19, 2004

Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the proteinRajesh Ambasudhan, XiaoFei Wang, Monica M Jablonski, et al.

Bioorganic & Medicinal Chemistry Letters|March 20, 2009

Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SARPenglie Zhang, Liang Bao, Jingmei Fan, et al.

Bioorganic & Medicinal Chemistry Letters|March 18, 2003

Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWenrong Huang, Mary Ann Naughton, Hua Yang, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2003

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitorsUma Sinha, Pei Hua Lin, Susan T Edwards, et al.

Bioorganic & Medicinal Chemistry Letters|July 1, 2004

Parallel synthesis and structure-activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitorsShawn M Bauer, Erick A Goldman, Wenrong Huang, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Molecular Vision|July 4, 2014

Generation of a foveomacular transcriptomeAlison Ziesel, Steven Bernstein, Paul W Wong

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002

Infantile cystinosis presenting as chronic constipationFarahnak K Assadi, Richard H Sandler, Paul W Wong, et al.

Genomics|March 19, 2004

Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expressionMd Nawajes A Mandal, Rajesh Ambasudhan, Paul W Wong, et al.

Investigative Ophthalmology & Visual Science|June 26, 2003

Evolutionarily conserved ELOVL4 gene expression in the vertebrate retinaPamela S Lagali, Jiafan Liu, Rajesh Ambasudhan, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 18, 2005

Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascadesAyala Hezi-Yamit, Paul W Wong, Nga Bien-Ly, et al.

Genomics|March 19, 2004

Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the proteinRajesh Ambasudhan, XiaoFei Wang, Monica M Jablonski, et al.

Bioorganic & Medicinal Chemistry Letters|March 20, 2009

Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SARPenglie Zhang, Liang Bao, Jingmei Fan, et al.

Bioorganic & Medicinal Chemistry Letters|March 18, 2003

Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWenrong Huang, Mary Ann Naughton, Hua Yang, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2003

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitorsUma Sinha, Pei Hua Lin, Susan T Edwards, et al.

Bioorganic & Medicinal Chemistry Letters|July 1, 2004

Parallel synthesis and structure-activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitorsShawn M Bauer, Erick A Goldman, Wenrong Huang, et al.

Pageof 2